Stifel Nicolaus restated their buy rating on shares of Physicians Realty Trust (NYSE:DOC) in a report released on Wednesday morning. The firm currently has a $22.00 price objective on the real estate investment trust’s stock.

Several other equities research analysts have also issued reports on DOC. BidaskClub raised shares of Physicians Realty Trust from a hold rating to a buy rating in a research note on Friday, June 23rd. Jefferies Group LLC reaffirmed a hold rating and issued a $21.00 price objective on shares of Physicians Realty Trust in a research note on Wednesday, June 14th. Cantor Fitzgerald reaffirmed a buy rating and issued a $23.00 price objective on shares of Physicians Realty Trust in a research note on Friday, June 30th. Morgan Stanley raised shares of Physicians Realty Trust from an underweight rating to an equal weight rating and set a $18.00 price objective for the company in a research note on Monday, July 24th. Finally, Raymond James Financial, Inc. lowered shares of Physicians Realty Trust from a strong-buy rating to an outperform rating and set a $21.00 price objective for the company. in a research note on Monday, July 17th. Six analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has a consensus rating of Buy and an average price target of $20.54.

Physicians Realty Trust (NYSE DOC) traded up 0.28% during mid-day trading on Wednesday, hitting $17.65. The stock had a trading volume of 2,102,486 shares. The firm’s 50-day moving average is $18.29 and its 200 day moving average is $19.34. The stock has a market cap of $2.78 billion, a PE ratio of 75.43 and a beta of 0.53. Physicians Realty Trust has a one year low of $17.12 and a one year high of $21.85.

Physicians Realty Trust (NYSE:DOC) last issued its earnings results on Thursday, August 3rd. The real estate investment trust reported $0.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. The company had revenue of $76.60 million during the quarter, compared to analyst estimates of $80.48 million. Physicians Realty Trust had a net margin of 11.51% and a return on equity of 1.75%. The company’s revenue for the quarter was up 43.9% on a year-over-year basis. During the same quarter last year, the business posted $0.22 EPS. Equities research analysts expect that Physicians Realty Trust will post $0.26 EPS for the current year.

TRADEMARK VIOLATION NOTICE: This story was first posted by Watch List News and is the property of of Watch List News. If you are reading this story on another website, it was illegally stolen and republished in violation of U.S. and international copyright & trademark legislation. The original version of this story can be viewed at https://www.watchlistnews.com/physicians-realty-trusts-doc-buy-rating-reaffirmed-at-stifel-nicolaus/1610776.html.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, October 18th. Investors of record on Tuesday, October 3rd will be issued a $0.23 dividend. The ex-dividend date is Monday, October 2nd. This represents a $0.92 annualized dividend and a yield of 5.23%. Physicians Realty Trust’s dividend payout ratio (DPR) is presently 400.02%.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Chicago Partners Investment Group LLC raised its holdings in Physicians Realty Trust by 603.8% in the 2nd quarter. Chicago Partners Investment Group LLC now owns 9,086 shares of the real estate investment trust’s stock worth $177,000 after acquiring an additional 7,795 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its holdings in Physicians Realty Trust by 16.8% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,462 shares of the real estate investment trust’s stock worth $191,000 after acquiring an additional 1,364 shares during the period. Pinnacle Associates Ltd. bought a new position in Physicians Realty Trust in the 2nd quarter worth $205,000. Quantbot Technologies LP raised its holdings in Physicians Realty Trust by 69.8% in the 1st quarter. Quantbot Technologies LP now owns 11,729 shares of the real estate investment trust’s stock worth $233,000 after acquiring an additional 4,821 shares during the period. Finally, Profund Advisors LLC raised its holdings in Physicians Realty Trust by 6.8% in the 2nd quarter. Profund Advisors LLC now owns 11,569 shares of the real estate investment trust’s stock worth $233,000 after acquiring an additional 733 shares during the period. Hedge funds and other institutional investors own 94.21% of the company’s stock.

About Physicians Realty Trust

Physicians Realty Trust (the Trust) is a real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems.

Analyst Recommendations for Physicians Realty Trust (NYSE:DOC)

Receive News & Ratings for Physicians Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physicians Realty Trust and related companies with Analyst Ratings Network's FREE daily email newsletter.